nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinapril—ACE—vein—testicular cancer	0.0684	0.466	CbGeAlD
Quinapril—ACE—embryo—testicular cancer	0.013	0.0883	CbGeAlD
Quinapril—ACE—seminal vesicle—testicular cancer	0.0122	0.0829	CbGeAlD
Quinapril—SLC15A2—seminal vesicle—testicular cancer	0.0106	0.0723	CbGeAlD
Quinapril—ACE—gonad—testicular cancer	0.00879	0.0599	CbGeAlD
Quinapril—ACE—female gonad—testicular cancer	0.00714	0.0487	CbGeAlD
Quinapril—ACE—testis—testicular cancer	0.00634	0.0432	CbGeAlD
Quinapril—SLC15A2—female gonad—testicular cancer	0.00623	0.0424	CbGeAlD
Quinapril—SLC15A2—testis—testicular cancer	0.00553	0.0376	CbGeAlD
Quinapril—ACE—lymph node—testicular cancer	0.00459	0.0313	CbGeAlD
Quinapril—SLC15A2—lymph node—testicular cancer	0.00401	0.0273	CbGeAlD
Quinapril—Breast disorder—Epirubicin—testicular cancer	0.00159	0.00186	CcSEcCtD
Quinapril—Abdominal pain—Ifosfamide—testicular cancer	0.00154	0.00181	CcSEcCtD
Quinapril—Anaphylactic shock—Etoposide—testicular cancer	0.00154	0.00181	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.00153	0.0018	CcSEcCtD
Quinapril—Infection—Etoposide—testicular cancer	0.00153	0.0018	CcSEcCtD
Quinapril—Asthenia—Dactinomycin—testicular cancer	0.00153	0.00179	CcSEcCtD
Quinapril—Paraesthesia—Cisplatin—testicular cancer	0.00151	0.00177	CcSEcCtD
Quinapril—Thrombocytopenia—Etoposide—testicular cancer	0.00151	0.00177	CcSEcCtD
Quinapril—Tachycardia—Etoposide—testicular cancer	0.00151	0.00177	CcSEcCtD
Quinapril—Liver function test abnormal—Doxorubicin—testicular cancer	0.0015	0.00176	CcSEcCtD
Quinapril—Dyspnoea—Cisplatin—testicular cancer	0.0015	0.00176	CcSEcCtD
Quinapril—Skin disorder—Etoposide—testicular cancer	0.0015	0.00176	CcSEcCtD
Quinapril—Erectile dysfunction—Methotrexate—testicular cancer	0.0015	0.00175	CcSEcCtD
Quinapril—Hyperhidrosis—Etoposide—testicular cancer	0.00149	0.00175	CcSEcCtD
Quinapril—Pancreatitis—Epirubicin—testicular cancer	0.00149	0.00175	CcSEcCtD
Quinapril—Orthostatic hypotension—Doxorubicin—testicular cancer	0.00149	0.00174	CcSEcCtD
Quinapril—Photosensitivity reaction—Methotrexate—testicular cancer	0.00148	0.00174	CcSEcCtD
Quinapril—Angina pectoris—Epirubicin—testicular cancer	0.00148	0.00174	CcSEcCtD
Quinapril—Breast disorder—Doxorubicin—testicular cancer	0.00147	0.00172	CcSEcCtD
Quinapril—Diarrhoea—Dactinomycin—testicular cancer	0.00146	0.00171	CcSEcCtD
Quinapril—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00145	0.0017	CcSEcCtD
Quinapril—Vomiting—Bleomycin—testicular cancer	0.00145	0.0017	CcSEcCtD
Quinapril—Infestation NOS—Methotrexate—testicular cancer	0.00145	0.0017	CcSEcCtD
Quinapril—Infestation—Methotrexate—testicular cancer	0.00145	0.0017	CcSEcCtD
Quinapril—Depression—Methotrexate—testicular cancer	0.00145	0.00169	CcSEcCtD
Quinapril—Rash—Bleomycin—testicular cancer	0.00144	0.00169	CcSEcCtD
Quinapril—Dermatitis—Bleomycin—testicular cancer	0.00144	0.00169	CcSEcCtD
Quinapril—Renal failure—Methotrexate—testicular cancer	0.00142	0.00167	CcSEcCtD
Quinapril—Asthenia—Ifosfamide—testicular cancer	0.0014	0.00164	CcSEcCtD
Quinapril—Photosensitivity reaction—Epirubicin—testicular cancer	0.00139	0.00163	CcSEcCtD
Quinapril—Feeling abnormal—Cisplatin—testicular cancer	0.00139	0.00163	CcSEcCtD
Quinapril—Paraesthesia—Etoposide—testicular cancer	0.00139	0.00162	CcSEcCtD
Quinapril—Pruritus—Ifosfamide—testicular cancer	0.00138	0.00162	CcSEcCtD
Quinapril—Pancreatitis—Doxorubicin—testicular cancer	0.00138	0.00162	CcSEcCtD
Quinapril—Dyspnoea—Etoposide—testicular cancer	0.00138	0.00161	CcSEcCtD
Quinapril—Somnolence—Etoposide—testicular cancer	0.00137	0.00161	CcSEcCtD
Quinapril—Angina pectoris—Doxorubicin—testicular cancer	0.00137	0.00161	CcSEcCtD
Quinapril—Hepatobiliary disease—Methotrexate—testicular cancer	0.00137	0.00161	CcSEcCtD
Quinapril—Nausea—Bleomycin—testicular cancer	0.00136	0.00159	CcSEcCtD
Quinapril—Infestation—Epirubicin—testicular cancer	0.00136	0.00159	CcSEcCtD
Quinapril—Infestation NOS—Epirubicin—testicular cancer	0.00136	0.00159	CcSEcCtD
Quinapril—Vomiting—Dactinomycin—testicular cancer	0.00136	0.00159	CcSEcCtD
Quinapril—Agranulocytosis—Methotrexate—testicular cancer	0.00135	0.00159	CcSEcCtD
Quinapril—Rash—Dactinomycin—testicular cancer	0.00134	0.00158	CcSEcCtD
Quinapril—Diarrhoea—Ifosfamide—testicular cancer	0.00134	0.00157	CcSEcCtD
Quinapril—Renal failure—Epirubicin—testicular cancer	0.00133	0.00156	CcSEcCtD
Quinapril—Gastrointestinal disorder—Etoposide—testicular cancer	0.00133	0.00156	CcSEcCtD
Quinapril—Fatigue—Etoposide—testicular cancer	0.00133	0.00156	CcSEcCtD
Quinapril—Constipation—Etoposide—testicular cancer	0.00132	0.00155	CcSEcCtD
Quinapril—Urinary tract infection—Epirubicin—testicular cancer	0.00132	0.00155	CcSEcCtD
Quinapril—Hepatitis—Methotrexate—testicular cancer	0.0013	0.00152	CcSEcCtD
Quinapril—Dizziness—Ifosfamide—testicular cancer	0.00129	0.00151	CcSEcCtD
Quinapril—Pharyngitis—Methotrexate—testicular cancer	0.00129	0.00151	CcSEcCtD
Quinapril—Urinary tract disorder—Methotrexate—testicular cancer	0.00128	0.00151	CcSEcCtD
Quinapril—Photosensitivity reaction—Doxorubicin—testicular cancer	0.00128	0.00151	CcSEcCtD
Quinapril—Hepatobiliary disease—Epirubicin—testicular cancer	0.00128	0.0015	CcSEcCtD
Quinapril—Urethral disorder—Methotrexate—testicular cancer	0.00128	0.00149	CcSEcCtD
Quinapril—Feeling abnormal—Etoposide—testicular cancer	0.00127	0.00149	CcSEcCtD
Quinapril—Nausea—Dactinomycin—testicular cancer	0.00127	0.00148	CcSEcCtD
Quinapril—Agranulocytosis—Epirubicin—testicular cancer	0.00127	0.00148	CcSEcCtD
Quinapril—Gastrointestinal pain—Etoposide—testicular cancer	0.00126	0.00148	CcSEcCtD
Quinapril—Infestation NOS—Doxorubicin—testicular cancer	0.00125	0.00147	CcSEcCtD
Quinapril—Infestation—Doxorubicin—testicular cancer	0.00125	0.00147	CcSEcCtD
Quinapril—Vomiting—Ifosfamide—testicular cancer	0.00124	0.00146	CcSEcCtD
Quinapril—Renal failure—Doxorubicin—testicular cancer	0.00123	0.00145	CcSEcCtD
Quinapril—Rash—Ifosfamide—testicular cancer	0.00123	0.00144	CcSEcCtD
Quinapril—Dermatitis—Ifosfamide—testicular cancer	0.00123	0.00144	CcSEcCtD
Quinapril—Abdominal pain—Etoposide—testicular cancer	0.00122	0.00143	CcSEcCtD
Quinapril—Urinary tract infection—Doxorubicin—testicular cancer	0.00122	0.00143	CcSEcCtD
Quinapril—Hepatitis—Epirubicin—testicular cancer	0.00122	0.00143	CcSEcCtD
Quinapril—Eye disorder—Methotrexate—testicular cancer	0.00122	0.00142	CcSEcCtD
Quinapril—Asthenia—Cisplatin—testicular cancer	0.00121	0.00142	CcSEcCtD
Quinapril—Pharyngitis—Epirubicin—testicular cancer	0.00121	0.00142	CcSEcCtD
Quinapril—Cardiac disorder—Methotrexate—testicular cancer	0.00121	0.00142	CcSEcCtD
Quinapril—Urinary tract disorder—Epirubicin—testicular cancer	0.0012	0.00141	CcSEcCtD
Quinapril—Connective tissue disorder—Epirubicin—testicular cancer	0.0012	0.0014	CcSEcCtD
Quinapril—Urethral disorder—Epirubicin—testicular cancer	0.00119	0.0014	CcSEcCtD
Quinapril—Hepatobiliary disease—Doxorubicin—testicular cancer	0.00119	0.00139	CcSEcCtD
Quinapril—Angiopathy—Methotrexate—testicular cancer	0.00118	0.00138	CcSEcCtD
Quinapril—Immune system disorder—Methotrexate—testicular cancer	0.00118	0.00138	CcSEcCtD
Quinapril—Mediastinal disorder—Methotrexate—testicular cancer	0.00117	0.00137	CcSEcCtD
Quinapril—Agranulocytosis—Doxorubicin—testicular cancer	0.00117	0.00137	CcSEcCtD
Quinapril—Nausea—Ifosfamide—testicular cancer	0.00116	0.00136	CcSEcCtD
Quinapril—Diarrhoea—Cisplatin—testicular cancer	0.00115	0.00135	CcSEcCtD
Quinapril—Alopecia—Methotrexate—testicular cancer	0.00115	0.00135	CcSEcCtD
Quinapril—Mental disorder—Methotrexate—testicular cancer	0.00114	0.00134	CcSEcCtD
Quinapril—Eye disorder—Epirubicin—testicular cancer	0.00114	0.00133	CcSEcCtD
Quinapril—Cardiac disorder—Epirubicin—testicular cancer	0.00113	0.00132	CcSEcCtD
Quinapril—Hepatitis—Doxorubicin—testicular cancer	0.00113	0.00132	CcSEcCtD
Quinapril—Pharyngitis—Doxorubicin—testicular cancer	0.00112	0.00131	CcSEcCtD
Quinapril—Urinary tract disorder—Doxorubicin—testicular cancer	0.00111	0.0013	CcSEcCtD
Quinapril—Asthenia—Etoposide—testicular cancer	0.00111	0.0013	CcSEcCtD
Quinapril—Connective tissue disorder—Doxorubicin—testicular cancer	0.00111	0.0013	CcSEcCtD
Quinapril—Angiopathy—Epirubicin—testicular cancer	0.0011	0.00129	CcSEcCtD
Quinapril—Urethral disorder—Doxorubicin—testicular cancer	0.0011	0.00129	CcSEcCtD
Quinapril—Immune system disorder—Epirubicin—testicular cancer	0.0011	0.00129	CcSEcCtD
Quinapril—Mediastinal disorder—Epirubicin—testicular cancer	0.0011	0.00129	CcSEcCtD
Quinapril—Back pain—Methotrexate—testicular cancer	0.0011	0.00128	CcSEcCtD
Quinapril—Pruritus—Etoposide—testicular cancer	0.00109	0.00128	CcSEcCtD
Quinapril—Arrhythmia—Epirubicin—testicular cancer	0.00109	0.00127	CcSEcCtD
Quinapril—Alopecia—Epirubicin—testicular cancer	0.00108	0.00126	CcSEcCtD
Quinapril—Vomiting—Cisplatin—testicular cancer	0.00107	0.00126	CcSEcCtD
Quinapril—Mental disorder—Epirubicin—testicular cancer	0.00107	0.00125	CcSEcCtD
Quinapril—Rash—Cisplatin—testicular cancer	0.00106	0.00124	CcSEcCtD
Quinapril—Dermatitis—Cisplatin—testicular cancer	0.00106	0.00124	CcSEcCtD
Quinapril—Diarrhoea—Etoposide—testicular cancer	0.00106	0.00124	CcSEcCtD
Quinapril—Eye disorder—Doxorubicin—testicular cancer	0.00105	0.00123	CcSEcCtD
Quinapril—Ill-defined disorder—Methotrexate—testicular cancer	0.00105	0.00123	CcSEcCtD
Quinapril—Cardiac disorder—Doxorubicin—testicular cancer	0.00105	0.00123	CcSEcCtD
Quinapril—Flatulence—Epirubicin—testicular cancer	0.00104	0.00122	CcSEcCtD
Quinapril—Tension—Epirubicin—testicular cancer	0.00104	0.00122	CcSEcCtD
Quinapril—Nervousness—Epirubicin—testicular cancer	0.00103	0.00121	CcSEcCtD
Quinapril—Back pain—Epirubicin—testicular cancer	0.00103	0.0012	CcSEcCtD
Quinapril—Angiopathy—Doxorubicin—testicular cancer	0.00102	0.0012	CcSEcCtD
Quinapril—Malaise—Methotrexate—testicular cancer	0.00102	0.0012	CcSEcCtD
Quinapril—Dizziness—Etoposide—testicular cancer	0.00102	0.0012	CcSEcCtD
Quinapril—Immune system disorder—Doxorubicin—testicular cancer	0.00102	0.00119	CcSEcCtD
Quinapril—Vertigo—Methotrexate—testicular cancer	0.00102	0.00119	CcSEcCtD
Quinapril—Mediastinal disorder—Doxorubicin—testicular cancer	0.00102	0.00119	CcSEcCtD
Quinapril—Arrhythmia—Doxorubicin—testicular cancer	0.00101	0.00118	CcSEcCtD
Quinapril—Nausea—Cisplatin—testicular cancer	0.001	0.00117	CcSEcCtD
Quinapril—Alopecia—Doxorubicin—testicular cancer	0.000995	0.00117	CcSEcCtD
Quinapril—Cough—Methotrexate—testicular cancer	0.000988	0.00116	CcSEcCtD
Quinapril—Mental disorder—Doxorubicin—testicular cancer	0.000987	0.00116	CcSEcCtD
Quinapril—Ill-defined disorder—Epirubicin—testicular cancer	0.000983	0.00115	CcSEcCtD
Quinapril—Vomiting—Etoposide—testicular cancer	0.000981	0.00115	CcSEcCtD
Quinapril—Rash—Etoposide—testicular cancer	0.000973	0.00114	CcSEcCtD
Quinapril—Dermatitis—Etoposide—testicular cancer	0.000972	0.00114	CcSEcCtD
Quinapril—Headache—Etoposide—testicular cancer	0.000967	0.00113	CcSEcCtD
Quinapril—Flatulence—Doxorubicin—testicular cancer	0.000966	0.00113	CcSEcCtD
Quinapril—Arthralgia—Methotrexate—testicular cancer	0.000964	0.00113	CcSEcCtD
Quinapril—Chest pain—Methotrexate—testicular cancer	0.000964	0.00113	CcSEcCtD
Quinapril—Myalgia—Methotrexate—testicular cancer	0.000964	0.00113	CcSEcCtD
Quinapril—Tension—Doxorubicin—testicular cancer	0.000962	0.00113	CcSEcCtD
Quinapril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000958	0.00112	CcSEcCtD
Quinapril—Malaise—Epirubicin—testicular cancer	0.000956	0.00112	CcSEcCtD
Quinapril—Discomfort—Methotrexate—testicular cancer	0.000953	0.00112	CcSEcCtD
Quinapril—Nervousness—Doxorubicin—testicular cancer	0.000952	0.00112	CcSEcCtD
Quinapril—Vertigo—Epirubicin—testicular cancer	0.000952	0.00112	CcSEcCtD
Quinapril—Syncope—Epirubicin—testicular cancer	0.00095	0.00111	CcSEcCtD
Quinapril—Back pain—Doxorubicin—testicular cancer	0.000949	0.00111	CcSEcCtD
Quinapril—Palpitations—Epirubicin—testicular cancer	0.000937	0.0011	CcSEcCtD
Quinapril—Loss of consciousness—Epirubicin—testicular cancer	0.000932	0.00109	CcSEcCtD
Quinapril—Cough—Epirubicin—testicular cancer	0.000925	0.00108	CcSEcCtD
Quinapril—Anaphylactic shock—Methotrexate—testicular cancer	0.000924	0.00108	CcSEcCtD
Quinapril—Infection—Methotrexate—testicular cancer	0.000918	0.00108	CcSEcCtD
Quinapril—Nausea—Etoposide—testicular cancer	0.000917	0.00107	CcSEcCtD
Quinapril—Ill-defined disorder—Doxorubicin—testicular cancer	0.00091	0.00107	CcSEcCtD
Quinapril—Nervous system disorder—Methotrexate—testicular cancer	0.000906	0.00106	CcSEcCtD
Quinapril—Thrombocytopenia—Methotrexate—testicular cancer	0.000905	0.00106	CcSEcCtD
Quinapril—Myalgia—Epirubicin—testicular cancer	0.000902	0.00106	CcSEcCtD
Quinapril—Arthralgia—Epirubicin—testicular cancer	0.000902	0.00106	CcSEcCtD
Quinapril—Chest pain—Epirubicin—testicular cancer	0.000902	0.00106	CcSEcCtD
Quinapril—Skin disorder—Methotrexate—testicular cancer	0.000898	0.00105	CcSEcCtD
Quinapril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000896	0.00105	CcSEcCtD
Quinapril—Hyperhidrosis—Methotrexate—testicular cancer	0.000894	0.00105	CcSEcCtD
Quinapril—Discomfort—Epirubicin—testicular cancer	0.000891	0.00104	CcSEcCtD
Quinapril—Malaise—Doxorubicin—testicular cancer	0.000884	0.00104	CcSEcCtD
Quinapril—Dry mouth—Epirubicin—testicular cancer	0.000882	0.00103	CcSEcCtD
Quinapril—Vertigo—Doxorubicin—testicular cancer	0.000881	0.00103	CcSEcCtD
Quinapril—Syncope—Doxorubicin—testicular cancer	0.000879	0.00103	CcSEcCtD
Quinapril—Palpitations—Doxorubicin—testicular cancer	0.000867	0.00102	CcSEcCtD
Quinapril—Anaphylactic shock—Epirubicin—testicular cancer	0.000865	0.00101	CcSEcCtD
Quinapril—Oedema—Epirubicin—testicular cancer	0.000865	0.00101	CcSEcCtD
Quinapril—Loss of consciousness—Doxorubicin—testicular cancer	0.000862	0.00101	CcSEcCtD
Quinapril—Infection—Epirubicin—testicular cancer	0.000859	0.00101	CcSEcCtD
Quinapril—Cough—Doxorubicin—testicular cancer	0.000856	0.001	CcSEcCtD
Quinapril—Shock—Epirubicin—testicular cancer	0.000851	0.000997	CcSEcCtD
Quinapril—Nervous system disorder—Epirubicin—testicular cancer	0.000848	0.000994	CcSEcCtD
Quinapril—Thrombocytopenia—Epirubicin—testicular cancer	0.000847	0.000993	CcSEcCtD
Quinapril—Tachycardia—Epirubicin—testicular cancer	0.000844	0.000989	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000842	0.000987	CcSEcCtD
Quinapril—Skin disorder—Epirubicin—testicular cancer	0.00084	0.000985	CcSEcCtD
Quinapril—Hyperhidrosis—Epirubicin—testicular cancer	0.000836	0.00098	CcSEcCtD
Quinapril—Insomnia—Methotrexate—testicular cancer	0.000836	0.00098	CcSEcCtD
Quinapril—Arthralgia—Doxorubicin—testicular cancer	0.000835	0.000978	CcSEcCtD
Quinapril—Chest pain—Doxorubicin—testicular cancer	0.000835	0.000978	CcSEcCtD
Quinapril—Myalgia—Doxorubicin—testicular cancer	0.000835	0.000978	CcSEcCtD
Quinapril—Paraesthesia—Methotrexate—testicular cancer	0.00083	0.000973	CcSEcCtD
Quinapril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000829	0.000972	CcSEcCtD
Quinapril—Discomfort—Doxorubicin—testicular cancer	0.000825	0.000967	CcSEcCtD
Quinapril—Dyspnoea—Methotrexate—testicular cancer	0.000824	0.000966	CcSEcCtD
Quinapril—Somnolence—Methotrexate—testicular cancer	0.000822	0.000963	CcSEcCtD
Quinapril—Dry mouth—Doxorubicin—testicular cancer	0.000817	0.000957	CcSEcCtD
Quinapril—Dyspepsia—Methotrexate—testicular cancer	0.000814	0.000954	CcSEcCtD
Quinapril—Anaphylactic shock—Doxorubicin—testicular cancer	0.0008	0.000938	CcSEcCtD
Quinapril—Oedema—Doxorubicin—testicular cancer	0.0008	0.000938	CcSEcCtD
Quinapril—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000798	0.000935	CcSEcCtD
Quinapril—Fatigue—Methotrexate—testicular cancer	0.000797	0.000934	CcSEcCtD
Quinapril—Infection—Doxorubicin—testicular cancer	0.000795	0.000932	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000788	0.000924	CcSEcCtD
Quinapril—Shock—Doxorubicin—testicular cancer	0.000787	0.000923	CcSEcCtD
Quinapril—Nervous system disorder—Doxorubicin—testicular cancer	0.000785	0.00092	CcSEcCtD
Quinapril—Thrombocytopenia—Doxorubicin—testicular cancer	0.000784	0.000918	CcSEcCtD
Quinapril—Insomnia—Epirubicin—testicular cancer	0.000782	0.000917	CcSEcCtD
Quinapril—Tachycardia—Doxorubicin—testicular cancer	0.000781	0.000915	CcSEcCtD
Quinapril—Skin disorder—Doxorubicin—testicular cancer	0.000777	0.000911	CcSEcCtD
Quinapril—Paraesthesia—Epirubicin—testicular cancer	0.000777	0.00091	CcSEcCtD
Quinapril—Hyperhidrosis—Doxorubicin—testicular cancer	0.000774	0.000907	CcSEcCtD
Quinapril—Dyspnoea—Epirubicin—testicular cancer	0.000771	0.000904	CcSEcCtD
Quinapril—Somnolence—Epirubicin—testicular cancer	0.000769	0.000901	CcSEcCtD
Quinapril—Feeling abnormal—Methotrexate—testicular cancer	0.000762	0.000893	CcSEcCtD
Quinapril—Dyspepsia—Epirubicin—testicular cancer	0.000761	0.000892	CcSEcCtD
Quinapril—Gastrointestinal pain—Methotrexate—testicular cancer	0.000756	0.000886	CcSEcCtD
Quinapril—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000747	0.000875	CcSEcCtD
Quinapril—Fatigue—Epirubicin—testicular cancer	0.000746	0.000874	CcSEcCtD
Quinapril—Constipation—Epirubicin—testicular cancer	0.00074	0.000867	CcSEcCtD
Quinapril—Abdominal pain—Methotrexate—testicular cancer	0.000731	0.000856	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000729	0.000855	CcSEcCtD
Quinapril—Insomnia—Doxorubicin—testicular cancer	0.000724	0.000848	CcSEcCtD
Quinapril—Paraesthesia—Doxorubicin—testicular cancer	0.000719	0.000842	CcSEcCtD
Quinapril—Dyspnoea—Doxorubicin—testicular cancer	0.000714	0.000836	CcSEcCtD
Quinapril—Feeling abnormal—Epirubicin—testicular cancer	0.000713	0.000835	CcSEcCtD
Quinapril—Somnolence—Doxorubicin—testicular cancer	0.000712	0.000834	CcSEcCtD
Quinapril—Gastrointestinal pain—Epirubicin—testicular cancer	0.000707	0.000829	CcSEcCtD
Quinapril—Dyspepsia—Doxorubicin—testicular cancer	0.000705	0.000826	CcSEcCtD
Quinapril—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000691	0.00081	CcSEcCtD
Quinapril—Fatigue—Doxorubicin—testicular cancer	0.00069	0.000809	CcSEcCtD
Quinapril—Constipation—Doxorubicin—testicular cancer	0.000684	0.000802	CcSEcCtD
Quinapril—Abdominal pain—Epirubicin—testicular cancer	0.000684	0.000801	CcSEcCtD
Quinapril—Asthenia—Methotrexate—testicular cancer	0.000663	0.000777	CcSEcCtD
Quinapril—Feeling abnormal—Doxorubicin—testicular cancer	0.00066	0.000773	CcSEcCtD
Quinapril—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000654	0.000767	CcSEcCtD
Quinapril—Pruritus—Methotrexate—testicular cancer	0.000654	0.000766	CcSEcCtD
Quinapril—Abdominal pain—Doxorubicin—testicular cancer	0.000633	0.000742	CcSEcCtD
Quinapril—Diarrhoea—Methotrexate—testicular cancer	0.000632	0.000741	CcSEcCtD
Quinapril—Asthenia—Epirubicin—testicular cancer	0.000621	0.000727	CcSEcCtD
Quinapril—Pruritus—Epirubicin—testicular cancer	0.000612	0.000717	CcSEcCtD
Quinapril—Dizziness—Methotrexate—testicular cancer	0.000611	0.000716	CcSEcCtD
Quinapril—Diarrhoea—Epirubicin—testicular cancer	0.000592	0.000694	CcSEcCtD
Quinapril—Vomiting—Methotrexate—testicular cancer	0.000588	0.000689	CcSEcCtD
Quinapril—Rash—Methotrexate—testicular cancer	0.000583	0.000683	CcSEcCtD
Quinapril—Dermatitis—Methotrexate—testicular cancer	0.000582	0.000682	CcSEcCtD
Quinapril—Headache—Methotrexate—testicular cancer	0.000579	0.000679	CcSEcCtD
Quinapril—Asthenia—Doxorubicin—testicular cancer	0.000574	0.000673	CcSEcCtD
Quinapril—Dizziness—Epirubicin—testicular cancer	0.000572	0.00067	CcSEcCtD
Quinapril—Pruritus—Doxorubicin—testicular cancer	0.000566	0.000664	CcSEcCtD
Quinapril—Vomiting—Epirubicin—testicular cancer	0.00055	0.000645	CcSEcCtD
Quinapril—Nausea—Methotrexate—testicular cancer	0.000549	0.000643	CcSEcCtD
Quinapril—Diarrhoea—Doxorubicin—testicular cancer	0.000548	0.000642	CcSEcCtD
Quinapril—Rash—Epirubicin—testicular cancer	0.000545	0.000639	CcSEcCtD
Quinapril—Dermatitis—Epirubicin—testicular cancer	0.000545	0.000639	CcSEcCtD
Quinapril—Headache—Epirubicin—testicular cancer	0.000542	0.000635	CcSEcCtD
Quinapril—Dizziness—Doxorubicin—testicular cancer	0.000529	0.00062	CcSEcCtD
Quinapril—Nausea—Epirubicin—testicular cancer	0.000514	0.000602	CcSEcCtD
Quinapril—Vomiting—Doxorubicin—testicular cancer	0.000509	0.000596	CcSEcCtD
Quinapril—Rash—Doxorubicin—testicular cancer	0.000505	0.000591	CcSEcCtD
Quinapril—Dermatitis—Doxorubicin—testicular cancer	0.000504	0.000591	CcSEcCtD
Quinapril—Headache—Doxorubicin—testicular cancer	0.000501	0.000588	CcSEcCtD
Quinapril—Nausea—Doxorubicin—testicular cancer	0.000475	0.000557	CcSEcCtD
